Results 11 to 20 of about 33,764 (311)
Thyrotropin reference interval in older adults
Endocrine ConnectionsIt is estimated that by the year 2050, 16% of the world’s population will be 65 years old and above. As the global aging population continues to grow, there is an increasing focus on thyroid disorders among older individuals.
Xiaodan Zhai +5 more
doaj +2 more sources
Relationship between thyrotropin and BMI in patients with subclinical hypothyroidism
Medicine Science, 2017 Subclinical hypothyroidism is an asymptomatic illness characterized by elevated serum thyrotropin and normal values of thyroid hormones. Currently, epidemiological studies have suggested a positive relationship between serum thyrotropin and body mass ...
Manuel Ivan Hernandez-Estala +3 more
doaj +2 more sources
Journal of Medical Case Reports, 2011 Introduction While thyrotropin-releasing hormone is known to be a prolactin-release stimulating factor, thyrotropin-releasing hormone-tartrate and its derivative, taltirelin hydrate, are used for the treatment of spinocerebellar degeneration, a ...
Kanasaki Haruhiko +4 more
doaj +1 more source
Interaction of Human Chorionic Gonadotropin (hCG) and Asialo-hCG with Recombinant Human Thyrotropin Receptor. [PDF]
, 1994 hCG is a putative thyroid stimulator. The present studies were undertaken to examine its interaction and that of its desialylated variant asialo-hCG with recombinant human TSH (hTSH) receptor (hTSHr). To this end, we transfected a human thyroid carcinoma
Mann, K. +4 more
core +1 more source
Metabolites, 2023 Low bone mass can occur in children and adolescents with numerous chronic conditions; however, the influence of abnormal thyroid hormone and thyroid-stimulating hormone (TSH) levels on low bone mineral density (BMD) in children and adolescents remains ...
Dongjin Lee, Moon Bae Ahn
doaj +1 more source
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
Antibodies, 2023 Autoimmune thyroid disease (AITD) refers to a spectrum of various diseases, with two extremes of clinical presentation, hypothyroidism (Hashimoto’s thyroiditis (HT) and hyperthyroidism (Graves–Basedow disease (GBD)).
Hernando Vargas-Uricoechea +3 more
doaj +1 more source
TRH: Pathophysiologic and clinical implications [PDF]
, 1985 Thyrotropin releasing hormone is thought to be a tonic stimulator of the pituitary TSH secretion regulating the setpoint of the thyrotrophs to the suppressive effect of thyroid hormones. The peptide stimulates the release of normal and elevated prolactin.
Pickardt, C. R., Scriba, Peter Christian
core +1 more source
A Genomic Point Mutation in the Extracellular Domain of the Thyrotropin Receptor in Patients with Graves’ Ophthalmopathy [PDF]
, 1994 Orbital and pretibial fibroblasts are targets of autoimmune attack in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). The fibroblast autoantigen involved in these peripheral manifestations of Graves' disease and the reason for the association
Sarkar, Gobinda +3 more
core +1 more source
Frontiers in Endocrinology, 2022 ObjectiveThyroid disorders are commonly concomitant with premature birth; however, indications to start therapy remain unclear due to a lack of gestational age (GA)-specific reference ranges.
Aleksandra Mikołajczak +2 more
doaj +1 more source
Independent Skeletal Actions of Pituitary Hormones [PDF]
Endocrinology and Metabolism, 2022 Over the past years, pituitary hormones and their receptors have been shown to have non-traditional actions that allow them to bypass the hypothalamus-pituitary-effector glands axis.
Se-Min Kim +5 more
doaj +1 more source